Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Severe diabetes associated with protease inhibitor therapy.

Visnegarwala F, Krause KL, Musher DM.

Ann Intern Med. 1997 Nov 15;127(10):947. No abstract available.

PMID:
9382374
2.

Diabetes mellitus associated with protease inhibitor use.

Rodríguez-Rosado R, Soriano V, Blanco F, Dona C, González-Lahoz J.

Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):675-7. No abstract available.

PMID:
10534196
3.

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.

Reijers MH, Weigel HM, Hart AA, Ten Kate RW, Mulder JW, Reiss P, Schuitemaker H, Hoetelmans RM, Weverling GJ, Lange JM.

AIDS. 2000 Jan 7;14(1):59-67.

PMID:
10714568
5.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA.

AIDS. 1998 May 7;12(7):F51-8.

PMID:
9619798
6.

[No selection of mutations. 908 raises genetic resistance barrier].

[No authors listed]

MMW Fortschr Med. 2003 Apr 28;145 Spec No 1:41. German. No abstract available.

PMID:
15011586
8.

Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge.

Di Martino V, Ezenfis J, Benhamou Y, Bernard B, Opolon P, Bricaire F, Poynard T.

AIDS. 1999 Jul 30;13(11):1421-3. No abstract available.

PMID:
10449303
9.

Protease inhibitor therapy-associated lipodystrophy, hypertriglyceridaemia and diabetes mellitus.

Paparizos VA, Kyriakis KP, Botsis C, Papastamopoulos V, Hadjivassiliou M, Stavrianeas NG.

AIDS. 2000 May 5;14(7):903-5. No abstract available.

PMID:
10839604
10.

New drug approved to treat HIV.

[No authors listed]

Treat Rev. 1997 Apr;(No 24):5.

PMID:
11364284
11.

[Protease inhibitor-associated hypertriglyceridemia and diabetes mellitus in HIV-infected patients].

Knobel H, Goday A, Grau S.

Med Clin (Barc). 1998 Nov 7;111(15):599. Spanish. No abstract available.

PMID:
9859098
12.

Exacerbated hyperglycemia associated with nelfinavir.

Paterson DL, Singh N.

Ann Pharmacother. 1998 May;32(5):609-10. No abstract available.

PMID:
9606484
13.

Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.

[No authors listed]

J Assoc Nurses AIDS Care. 2002 Mar-Apr;13(2):86-7. No abstract available.

PMID:
11936070
14.

New-onset diabetes mellitus associated with use of protease inhibitor.

Eastone JA, Decker CF.

Ann Intern Med. 1997 Nov 15;127(10):948. No abstract available.

PMID:
9382376
15.

Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.

Bates DE, Herman RJ.

Ann Pharmacother. 2006 Jun;40(6):1190-5. Epub 2006 May 23.

PMID:
16720703
16.

New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

Lee EC, Walmsley S, Fantus IG.

CMAJ. 1999 Jul 27;161(2):161-4. Review. No abstract available.

17.

Viracept and irregular heartbeat warning.

Fornataro K, Jefferys R.

Body Posit. 1999 Oct;12(10):10, 12.

PMID:
11366874
18.

Lipodystrophy: results of a data evaluation of patients receiving nelfinavir-containing combination therapy.

Lewis RH, Popescu M.

J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):355-6. No abstract available.

PMID:
10836759
19.

Paronychia in an HIV-infected patient under nelfinavir therapy.

Domínguez MV, Ceballos VC, Costa RV, Lara TE, Florencio VD.

J Eur Acad Dermatol Venereol. 2007 May;21(5):710-1. No abstract available.

PMID:
17448006
20.

Health advisory: high blood sugar and diabetes seen in protease inhibitor users.

[No authors listed]

Crit Path AIDS Proj. 1997 Summer;(No 32):28.

PMID:
11364437

Supplemental Content

Support Center